Skip to main content
Contact Us
Subscribe
E-Edition
72°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Archives
Best of 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about RHHBY
Recent news which mentions RHHBY
< Previous
1
2
...
11
12
13
14
15
16
17
18
Next >
The OTCQX's Top 10 Experience A Shuffle In February
March 15, 2022
Tickers
ADDYY
ETHE
GBOOY
GBTC
Tags
HEINY
ZURVY
Small Cap
From
Benzinga
The Daily Biotech Pulse: Biogen, Eisai Amend Aduhelm Agreement; Anaptys Acne Drug Flunks Midstage Study; Merck, AstraZeneca Discontinue Prostate Cancer Trial
March 15, 2022
Tickers
ALT
ANAB
ANIP
ATHX
Tags
BAYRY
ATHX
BBI
From
Benzinga
Exelixis Will Not Pursue Untreated Liver Cancer Indication For Cabometyx Combo Therapy
March 15, 2022
Tickers
BAYRY
BAYZF
EXEL
IPSEY
Tags
EXEL
Liver Cancer
Biotech
From
Benzinga
Biogen Posts New Updates Across its Spinraza SMA Research Program
March 14, 2022
Tickers
BIIB
NVS
RHHBY
Tags
General
News
Benzinga
From
Benzinga
The Week Ahead In Biotech (March 13-19): Bristol-Myers Squibb's Melanoma Drug Decision, Multiple Conference Presentations And Earnings Dominate Proceedings
March 13, 2022
Tickers
ACIU
ADAP
ALDX
ALEC
Tags
CPRX
BBI
IKT
From
Benzinga
OTC Markets 2021 Annual Data Review Highlights A Record 60% $ Volume Increase
March 07, 2022
Tickers
BVNNF
GBTC
OTCM
RHHBY
Tags
Market News
RHHBY
Small Cap
From
Benzinga
Up 1,000% in 5 Years? These Healthcare Stocks Could Pull It Off.
March 04, 2022
Tickers
AZN
HRTX
JNJ
LEGN
Tags
HRTX
SGEN
Recent Press Releases
From
Motley Fool
Viatris Just Snagged a Major FDA Approval
March 03, 2022
Tickers
ABBV
NVS
REGN
RHHBY
Tags
SNY
REGN
Market News
From
Motley Fool
2 Biotech Stocks That Could Make You Richer
March 02, 2022
Tickers
BMY
EXEL
ICPT
RHHBY
Tags
Market News
RHHBY
EXEL
From
Motley Fool
Roche And AstraZeneca Settle Ultomiris Patent Lawsuit
February 22, 2022
Tickers
AZN
AZNCF
RHHBY
TAK
Tags
News
Legal
Health Care
From
Benzinga
Sanofi-Regeneron's Dupixent Falls Short In Chronic Spontaneous Urticaria Trial
February 18, 2022
Tickers
ANY
NVS
REGN
RHHBF
Tags
REGN
Health Care
RHHVF
From
Benzinga
3 Cutting-Edge, Protein-Degrader Biotech Stocks to Watch
February 16, 2022
Tickers
ARVN
BIIB
CCCC
GOOG
Tags
Recent Press Releases
CCCC
VRTX
From
Motley Fool
These OTC Securities Reported The Most Trading Volume In January – With Possible Sustained Interest In International Operators
February 14, 2022
Tickers
BNPQY
CYDY
EEENF
ETHE
Tags
EEENF
otc
Penny Stocks
From
Benzinga
Why Are Seagen Shares Sinking Today?
February 10, 2022
Tickers
GSK
MRK
RHHBY
SGEN
Tags
Benzinga
why it's moving
General
From
Benzinga
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More
February 06, 2022
Tickers
ABBV
ACLX
ALNY
AMGN
Tags
INSP
AVRO
Food and Drug Administration
From
Benzinga
Cathie Wood's Ark Invest Sheds Stake In This Large-Cap Pharma Ahead Of Earnings
February 05, 2022
Tickers
ARKG
BNTX
MRK
PFE
Tags
ARKG
REGN
Benzinga
From
Benzinga
The Daily Biotech Pulse: Big Pharma Earnings Prove Lackluster, Mersana Inks $1B ADC R&D Deal, Syros Gets Orphan Drug Designation
February 03, 2022
Tickers
ABMD
ARWR
BIIB
BMY
Tags
ARWR
Benzinga
MRK
From
Benzinga
Roche Expects Slower FY22 Sales Growth On Lower Demand For COVID-19 Tests
February 03, 2022
Tickers
NVS
RHHBF
RHHBY
RHHVF
Tags
RHHBF
Market News
NVS
From
Benzinga
Novartis Expects FY22 Sales, Profit Growth; Sandoz Review Continues
February 02, 2022
Tickers
NVS
RHHBF
RHHBY
RHHVF
Tags
RHHVF
Health Care
News
From
Benzinga
Biogen Exercises Option To Participate Developing Genentech's Bispecific Antibody, Mosunetuzumab
February 01, 2022
Tickers
BIIB
RHHBF
RHHBY
RHHVF
Tags
Biotech
RHHBY
Diffuse Large B/Cell Lymphoma
From
Benzinga
The Week Ahead In Biotech (Jan 31-Feb 5): Merck, Bristol-Myers Squibb, Lilly & Novartis Headline Large-Cap Biopharma Earnings News
January 31, 2022
Tickers
ABBV
ABMD
AMLX
ARWR
Tags
Top Stories
VIVO
ABMD
From
Benzinga
FDA Approves First Injectable Eye Medicine For Vision Loss Disorder - Genentech's Vabysmo
January 31, 2022
Tickers
RHHBF
RHHBY
RHHVF
Tags
Health Care
Age/Related Macular Degeneration
RHHVF
From
Benzinga
Genentech's Evrysdi Application Under FDA Priority Review For Use In Babies Below 2 Months
January 25, 2022
Tickers
RHHBF
RHHBY
RHHVF
Tags
Biotech
RHHBY
RHHBF
From
Benzinga
These OTC Securities Had the Most Trading Activity in December
January 25, 2022
Tickers
ADDYY
AKZOY
BNPQY
CYDVF
Tags
FNMA
VRNOF
NLST
From
Benzinga
3 Clinical Trials to Watch in the First Half of 2022
January 22, 2022
Tickers
ABBV
ARNA
BIIB
JPM
Tags
VRTX
ABBV
Recent Press Releases
From
Motley Fool
2 Risky Growth Stocks That Could Make You Filthy Rich
January 16, 2022
Tickers
AZN
BGNE
JPM
LPTX
Tags
LPTX
JPM
PIRS
From
Motley Fool
Where Will Biogen Be in 5 Years?
January 15, 2022
Tickers
BIIB
NVS
RHHBY
SAGE
Tags
BIIB
SAGE
RHHBY
From
Motley Fool
Medicare pulls back on coverage of an Alzheimer’s drug
January 12, 2022
Tickers
BIIB
LLY
RHHBY
Tags
RHHBY
BIIB
LLY
From
MarketWatch
CMS Proposes Coverage Of Biogen's Alzheimer's Drug, With Conditions Apply
January 12, 2022
Tickers
BIIB
ESALF
ESALY
LLY
Tags
RHHBY
Government
FDA
From
Benzinga
Why Shares of ImmunoGen Jumped 20.3% in December
January 03, 2022
Tickers
IMGN
RHHBY
Tags
Recent Press Releases
Market News
IMGN
From
Motley Fool
< Previous
1
2
...
11
12
13
14
15
16
17
18
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.